Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Polycystic Ovary Syndrome × Therapeutics × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 2 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pain 1 Nevus, Sebaceous of Jadassohn 1 Neoplasms 1 Carcinoma, Basal Cell 1 Agnosia 1

Interventions

Metformin 38 Clomiphene 15 Menotropins 5 Letrozole 5 drospirenone and ethinyl estradiol combination 4 Folic Acid 4 Chorionic Gonadotropin 4 cetrorelix 3 Triptorelin Pamoate 3 Progesterone 3 Pioglitazone 3 Liraglutide 3 Leuprolide 3 Inositol 3 Exenatide 3 Ethinyl Estradiol 3 Estradiol 3 Vitamins 2 Sperm Injections, Intracytoplasmic 2 Sitagliptin Phosphate 2 Simvastatin 2 Gonadotropins 2 Glycoprotein Hormones, alpha Subunit 2 Exercise 2 Escitalopram 2 Cyproterone acetate, ethinyl estradiol drug combination 2 Cholecalciferol 2 Carnitine 2 Canagliflozin 2 Caloric Restriction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00378729 2011-10-04

PERCING

Assistance Publique - Hôpitaux de Paris

Phase 4 Unknown

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡